MAR 25, 2021 8:00 AM PDT

Aperio VERSA - Visikol's Highly Multiplexed Immunohistochemistry Approach to Drug Discovery

Sponsored by: Leica Biosystems

Event Date & Time
Date:  March 25, 2021
Time: 8:00am (PDT),  11:00am (EDT)
Visikol is a biotechnology company focused on advanced imaging, digital pathology and 3D cell culture assays that has developed a unique imaging platform that allows for 10+ plex immunofluorescent slide imaging. Through this presentation, Visikol will provide a background on various multiplex tissue imaging approaches and will describe how they can be used to answer complex research questions such as surveying the immune cell population within a tumor microenvironment or evaluating therapeutics for infectious diseases. Specifically, Visikol will discuss how its proprietary multiplex approach has been leveraged through a partnership with Hackensack Meridian Health (HMH) to evaluate tuberculosis treatments. This work is funded by the Bill & Melinda Gates Foundation using Visikol's multiplex approach combined with several other imaging modalities to evaluate treatments using a multi-modal imaging approach.
Learning Objectives
  • Develop an understanding of multiplex slide labeling and imaging techniques.
  • Demonstrate a working knowledge of the multiple types of multiplex tools available for whole slide imaging.
  • Identify the unique types of research questions that can be addressed through multiplex imaging.
Webinars will be available for unlimited on-demand viewing after live event.
For Research Use Only. Not for Use in Diagnostic Procedures
LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.

You May Also Like
Loading Comments...